Tunlametinib (HL-085) is an oral, selective, mitogen-activated protein kinase kinase 1 and 2 (MEK 1/2) inhibitor, for…
About Disitamab Vedotin An antibody-drug conjugate (ADC) composed of trastuzumab, a humanized immunoglobulin G1 (IgG1) monoclonal…
About Anlotinib Anlotinib is a orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor…
Entinostat is a synthetic drug that inhibits histone deacetylase (HDAC) enzymes. Entinostat sold as brand name 景助达® …
Surufatinib is a novel, oral angio-immuno kinase inhibitor that selectively inhibits the tyrosine kinase activity associated…
About Iparomlimab/Tuvonralimab A mixture of the two engineered monoclonal antibodies iparomlimab, which is an immunoglobulin G4…
Pamiparib (BGB-290) is a drug used to treat various types of cancer. It's a PARP inhibitor,…
Socazolimab is a fully human anti-PD-L1 (programmed cell death 1 ligand 1) monoclonal antibody, an immune checkpoint…